30 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
Opportunistic Infections in HIV/AIDS: Syndromic Approach

WuidQ: Washington University ID Questions @WuidQ

#Opportunistic #Infections #OIs #HIVAIDS #Differential #Diagnosis
Opportunistic Infections ... in HIV/AIDS: Syndromic ... #OIs #HIVAIDS # ... Differential #Diagnosis ... #Systems #Syndromes
Syndromic Approach to Opportunistic Infections in HIV/AIDS: 

WuidQ: Washington University ID Questions @WuidQ

#Opportunistic #Infections #OIs #HIVAIDS
Opportunistic Infections ... in HIV/AIDS: ... #OIs #HIVAIDS # ... Differential #Diagnosis ... #Systems #Syndromes
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... known to have HIV ... diagnosed with HIV ... • Women with HIV ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Bacterial Enteric Infections ... in HIV-AIDS Preventing ... Enteric #Bacterial #IDSA ... #HIVAIDS #pharmacology
Etiologies of dilated cardiomyopathy. HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HIV, human
ejection fraction; HIV ... - Genetic - Systemic ... disease - Infection ... cardiomyopathy #differential ... #diagnosis #cardiology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Candidiasis in HIV-AIDS ... 21 days) Note: Systemic ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... ) Infections in ... HIV-AIDS Treating ... #IDSA #Prevention ... #HIVAIDS #pharmacology